ArticleHaematologica2017

Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells.

Jueqiong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.